DXPRO Trademark

Trademark Overview

On Friday, May 12, 2023, a trademark application was filed for DXPRO with the United States Patent and Trademark Office. The USPTO has given the DXPRO trademark a serial number of 97933971. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Saturday, November 2, 2024. This trademark is owned by Tessellon, Inc.. The DXPRO trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing medical information, namely, a database of statistical epidemiological data relating to cancer diagnoses and procedures.
dxpro

General Information

Serial Number97933971
Word MarkDXPRO
Filing DateFriday, May 12, 2023
Status645 - FINAL REFUSAL - MAILED
Status DateSaturday, November 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkDIAGNOSIS AND PROCEDURE
Goods and ServicesProviding medical information, namely, a database of statistical epidemiological data relating to cancer diagnoses and procedures.

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, May 22, 2024
Primary Code044
First Use Anywhere DateTuesday, April 1, 2008
First Use In Commerce DateTuesday, April 1, 2008

Trademark Owner History

Party NameTessellon, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChesterfield, MO 63055

Trademark Events

Event DateEvent Description
Tuesday, May 16, 2023NEW APPLICATION ENTERED
Monday, June 12, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 22, 2024NON-FINAL ACTION WRITTEN
Thursday, February 22, 2024NON-FINAL ACTION E-MAILED
Thursday, February 22, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 22, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 6, 2024ASSIGNED TO EXAMINER
Wednesday, May 22, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 22, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 2, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 2, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 2, 2024NON-FINAL ACTION E-MAILED
Tuesday, July 2, 2024NON-FINAL ACTION WRITTEN
Wednesday, October 2, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 2, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, November 2, 2024FINAL REFUSAL WRITTEN
Friday, January 31, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, January 31, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Saturday, November 2, 2024FINAL REFUSAL E-MAILED
Saturday, November 2, 2024NOTIFICATION OF FINAL REFUSAL EMAILED

Related Keywords

dxpro relating data cancer diagnoses procedures epidemiological statistical medical information namely